Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
862,01 B | 23,47% | 6/6 | 38,18% | 15,22% | 29,76% | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.232,71 B | 20,54% | 5/6 | -8,58% | 60,85% | 3,42% | DOWN |
|
Altimmune NasdaqGM:ALT |
0,55 B | -70,21% | 2/5 | -100,00% | -1516,68% | 609,22% | DOWN |



































